Accelerated development of vaccine benefit-risk collaboration in Europe

The goal of the ADVANCE project is to develop a blueprint for a framework capable of rapidly delivering reliable data on the benefits and risks of vaccines. The framework will support health professionals, regulatory agencies, public health institutions and the general public make better informed decisions on immunisation.The ADVANCE project represents unique collaboration between key stakeholders in the sector, including European Centre for Disease Prevention and Control (ECDC), European Medicines Agency (EMA), national public health and regulatory bodies, vaccine manufacturers, SMEs, and academic institutions.

[separator size=’small’ margin=’small’/]

ADVANCE project flyer

ADVANCE project website
[separator size=’small’ margin=’small’/]